Literature DB >> 8299950

Construction of Tn4001lac derivatives to be used as promoter probe vectors in mycoplasmas.

K L Knudtson1, F C Minion.   

Abstract

Studies of gene expression in mycoplasmas has been difficult, because the elements involved in gene expression remain relatively undefined. In order to be able to examine these regulatory elements in vivo, derivatives of Tn4001 containing the promoterless Escherichia coli lacZ reporter gene have been constructed. A Tn4001lac derivative, Tn4001.2062.2lac, transforms Mycoplasma gallisepticum and Acholeplasma strain ISM1499. Approximately 3% of the M. gallisepticum and 8% of the Acholeplasma ISM1499 transformants appeared to generate lacZ fusions based on blue colony formation on XGal-containing media. However, placement of lacZ into an IS256 arm of Tn4001 resulted in a derivative that transformed at a frequency about 3-7-fold lower than that of wild-type Tn4001. Another Tn4001lac derivative, Tn4001.2065, possesses a plasmid, as well as lacZ, in the IS256 arm. This construct was designed to permit the direct rescue of adjacent chromosomal sequences that are driving the expression of lacZ contained within the transposon. These constructs should be useful in locating and defining the upstream elements involved in mycoplasma gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8299950     DOI: 10.1016/0378-1119(93)90009-r

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  38 in total

1.  Transcriptional analysis of the hmw gene cluster of Mycoplasma pneumoniae.

Authors:  R H Waldo; P L Popham; C E Romero-Arroyo; E A Mothershed; K K Lee; D C Krause
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

2.  Gene transfer in Mycoplasma pulmonis.

Authors:  Amy M Teachman; C Todd French; Huilan Yu; Warren L Simmons; Kevin Dybvig
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

3.  Characterization of a Mycoplasma pneumoniae hmw3 mutant: implications for attachment organelle assembly.

Authors:  Melisa J Willby; Duncan C Krause
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

4.  Phenotypic switching in Mycoplasma gallisepticum hemadsorption is governed by a high-frequency, reversible point mutation.

Authors:  Florian Winner; Ivana Markovà; Peter Much; Albin Lugmair; Karin Siebert-Gulle; Gunther Vogl; Renate Rosengarten; Christine Citti
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

5.  GapA and CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and virulence.

Authors:  L Papazisi; S Frasca; M Gladd; X Liao; D Yogev; S J Geary
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Use of fluorescent-protein tagging to determine the subcellular localization of mycoplasma pneumoniae proteins encoded by the cytadherence regulatory locus.

Authors:  Tsuyoshi Kenri; Shintaro Seto; Atsuko Horino; Yuko Sasaki; Tsuguo Sasaki; Makoto Miyata
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

7.  Targeted chromosomal knockouts in Mycoplasma pneumoniae.

Authors:  Radha Krishnakumar; Nacyra Assad-Garcia; Gwynedd A Benders; Quang Phan; Michael G Montague; John I Glass
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

8.  Xer1-mediated site-specific DNA inversions and excisions in Mycoplasma agalactiae.

Authors:  Stefan Czurda; Wolfgang Jechlinger; Renate Rosengarten; Rohini Chopra-Dewasthaly
Journal:  J Bacteriol       Date:  2010-06-18       Impact factor: 3.490

9.  GAA trinucleotide repeat region regulates M9/pMGA gene expression in Mycoplasma gallisepticum.

Authors:  L Liu; K Dybvig; V S Panangala; V L van Santen; C T French
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

10.  Identification of a virulence-associated determinant, dihydrolipoamide dehydrogenase (lpd), in Mycoplasma gallisepticum through in vivo screening of transposon mutants.

Authors:  P Hudson; T S Gorton; L Papazisi; K Cecchini; S Frasca; S J Geary
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.